Urica Therapeutics is a clinical-stage biopharmaceutical company that focuses on the development and commercialization of pharmaceutical products to treat gout and chronic kidney disease. Urica was founded by Fortress Biotech, Inc. (NASDAQ: FBIO).
Urica Therapeutics is a clinical-stage biopharmaceutical company that focuses on the development and commercialization of pharmaceutical products to treat gout and chronic kidney disease. Urica was founded by Fortress Biotech, Inc. (NASDAQ: FBIO).